Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4171 AL 4185

Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study

Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.

J Am Med Dir Assoc. 2012 Jun;13(5):477-84. doi: 10.1016/j.jamda.2012.03.005. Epub 2012 Apr 20.

Long-term health implications of individuals with TBI: a rehabilitation perspective

Murphy MP, Carmine H.

NeuroRehabilitation. 2012;31(1):85-94. doi: 10.3233/NRE-2012-0777.

Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury

Wu J, Sun T, Ye C, Yao J, Zhu B, He H.

Cell Transplant. 2012;21 Suppl 1:S33-7. doi: 10.3727/096368912X633743.

Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life

Sharma A, Gokulchandran N, Chopra G, Kulkarni P, Lohia M, Badhe P, Jacob VC.

Cell Transplant. 2012;21 Suppl 1:S79-90. doi: 10.3727/096368912X633798.

Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity

Oreja-Guevara C.

Expert Rev Neurother. 2012 Apr;12(4 Suppl):3-8. doi: 10.1586/ern.12.11.

Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?

Wade D.

Expert Rev Neurother. 2012 Apr;12(4 Suppl):9-14. doi: 10.1586/ern.12.12.

Cellular pathways of hereditary spastic paraplegia

Blackstone C.

Annu Rev Neurosci. 2012;35:25-47. doi: 10.1146/annurev-neuro-062111-150400. Epub 2012 Apr 20.

Strength: a relevant link to functional performance in the neurodegenerative disease of adrenomyeloneuropathy

Keller JL, Wang JI, Kang JY, Hanson JA, Kamath P, Swain JO, Raymond GV, Zackowski KM.

Neurorehabil Neural Repair. 2012 Nov-Dec;26(9):1080-8. doi: 10.1177/1545968312441682. Epub 2012 Apr 27.

Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance

Finsterer J, Löscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G.

J Neurol Sci. 2012 Jul 15;318(1-2):1-18. doi: 10.1016/j.jns.2012.03.025. Epub 2012 May 1.

Ultrasonographic measurement of the femoral cartilage thickness in hemiparetic patients after stroke

Tunç H, Oken O, Kara M, Tiftik T, Doğu B, Unlü Z, Ozçakar L.

Int J Rehabil Res. 2012 Sep;35(3):203-7. doi: 10.1097/MRR.0b013e3283532736.

Spasticity following spinal cord injury

Rekand T, Hagen EM, Grønning M.

Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):970-3. doi: 10.4045/tidsskr.10.0872.

Severity score system for progressive myelopathy: development and validation of a new clinical scale

Castilhos RM, Blank D, Netto CB, Souza CF, Fernandes LN, Schwartz IV, Giugliani R, Jardim LB.

Braz J Med Biol Res. 2012 Jul;45(7):565-72. doi: 10.1590/s0100-879x2012007500072. Epub 2012 May 10.

[Cannabinoid drugs for neurological diseases: what is behind?]

Fernández-Ruiz J.

Rev Neurol. 2012 May 16;54(10):613-28.

Potential control of multiple sclerosis by cannabis and the endocannabinoid system

Pryce G, Baker D.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):624-41. doi: 10.2174/187152712801661310.

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B.

CMAJ. 2012 Jul 10;184(10):1143-50. doi: 10.1503/cmaj.110837. Epub 2012 May 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias